الثلاثاء 9 جمادى الأولى 1448هـ
جميع روابط المواقع الرسمية التابعة للجهات الحكومية في المملكة العربية السعودية تنتهي بـ .gov.sa
تحقق من أن الموقع يستخدم بروتوكول HTTPS
مسجل لدى هيئة الحكومة الرقمية برقم :
| عنوان الدراسة | داعم الدراسة | حالة الدراسة | دواء الدراسة | مرحلة الدراسة | رقم بروتوكول الدراسة | موقع الدراسة |
|---|---|---|---|---|---|---|
| Efficacy and Safety Assessment of NIlotinib in Chronic Myeloid Leukemia (CML) Patients with Suboptimal Response on Imatinib Therapy (NISRI) | KAIMRC | Ongoing | NILOTINIB | 4 | RC12/052/R | King Abdulaziz Medical City NG (Riyadh), King Fahad Specialist Hospital (Dammam) |
| Aspirin for Dukes C and High Risk Dukes B Colorectal Cancers, An International, Multicenter, Double Blind, Randomized Placebo Controlled Phase 3 trial (ICR-02/ASCOLT) | King Fahad Medical City | Ongoing | Aspirin | 3 | ICR-02/ASCOLT | King Fahad Medical City (Riyadh) |
| A study of the factors predicting radiation exposure to contacts of Saudi patients treated with radioactive iodine (I 131): A preliminary study for patients’ criteria selection for possible high dose I131 therapy on out-patient basis in the future | King Abdulaziz City for Science and Technology (KACST) | Completed | 131 Iodine | 4 | (version#1) dated 10-Apr-14 | King Abdullah Medical City (Makkah) |
| Middle East Observational Study in Metastatic Soft Tissue Sarcoma: An epidemiological study on the treatment patterns | Novartis | Ongoing | N/A | 4 | VEG201319 | King Faisal Specialist Hospital and Research Center (Riyadh) |
| Prospective, multicentre, international Registry of male and female patients newly diagnosed with Atrial Fibrillation and treated with Rivaroxaban | Thrombosis Research Institute | Ongoing | Rivaroxaban | 4 | TRI08890 | Armed Forces Hospital (Southern Region) |
| (FLASH study)A 12-week treatment, multi-center, randomized, doubleblind,double-dummy, parallel group study to assess the efficacy and safety of switching fromsalmeterol/fluticasone to QVA149 (indacaterolmaleate/glycopyrronium bromide) in symptomatic COPD patients | Novartis | Ongoing | Ultibro breezhaler | 4 | A3405 V01 | King Fahad Medical City (Riyadh), King Fahad University Hospital (Al-Khobar), King Abdulaziz Medical City NG (Jeddah) |
| XALIA LEA- Xarelto® for Long-term and Initial Anticoagulation in VenousThromboembolism (VTE) in Latin America,EMEA and Asia | Bayer | Ongoing | Rivaroxaban | 4 | 17237 | King Fahad Medical City (Riyadh), King Fahad Hospital (Madinah), King Faisal Hospital (Taif), Hira Hospital (Makkah) |
| Prospective Multicentre Observational Registry Of Treatments And Outcomes In Patients With Chronic | Astellas Pharma International | Ongoing | N/A | 4 | ONC-MA1002 | Aseer Central Hospital |
| Early Goal Directed Sedation vs. Standard Care Sedation | The Australian and New Zealand Intensive Care Research Centre, Monash University, Australia | Ongoing | Dexmedetomidine | 4 | YS/003 | King Saud Medical City (Riyadh) |
| Efficacy of Different Mouthwashes in the Reduction of Halitosis: A Randomized, Double Blind, Placebo-Controlled, Crossover Clinical Trial | King Abdulaziz City for Science and Technology (KACST) | Ongoing | Halita - AO ProRinse | 4 | PR oo39 | College of Dentistry King Saud University |
تاريخ آخر تحديث: 06/10/2026 بتمام الساعة 08:14 صباحا بتوقيت المملكة العربية السعودية
لم يتم تقديم أي تقييمات لهذه الصفحة بعد.
التعليقات والاقتراحات
لأي استفسارات أو ملاحظات حول الخدمات الحكومية، يرجى تعبئة المعلومات المطلوبة.